Vanda Pharmaceuticals Inc...

4.50
-0.09 (-1.96%)
At close: Apr 01, 2025, 3:59 PM
4.64
3.14%
After-hours: Apr 01, 2025, 07:56 PM EDT

Vanda Pharmaceuticals Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20
Net Income -18.9M 2.51M 6.28M 33.15M 23.34M
Depreciation & Amortization -6.13M 3.01M 2.73M 2.84M 2.86M
Stock-Based Compensation 12.43M 14.04M 16.28M 15.37M 13.36M
Other Working Capital n/a 11.71M -151K 4.4M 3.13M
Other Non-Cash Items 3.33M -4.72M -507K 3.37M 1.71M
Deferred Income Tax -6.48M -1.29M 1.13M 6.75M 6.19M
Change in Working Capital n/a -747K 6.07M 2.74M 4.32M
Operating Cash Flow -15.76M 12.8M 31.98M 64.21M 51.77M
Capital Expenditures -490K -383K -679K -552K -1.79M
Acquisitions n/a -100.67M -50.6M -12K -229K
Purchase of Investments -364.77M -512.61M -349.26M -420.46M -346.62M
Sales Maturities Of Investments 352.06M 601.6M 399.86M 344.32M 306.92M
Other Investing Acitivies -4.23M n/a 50.6M 12K 229K
Investing Cash Flow -17.43M -12.06M 49.92M -76.7M -41.5M
Debt Repayment -155K n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies n/a n/a 734K 3.55M 5.63M
Financial Cash Flow -155K n/a 734K 3.55M 5.63M
Net Cash Flow -33.51M 792K 82.91M -9.02M 15.96M
Free Cash Flow -16.25M 12.42M 31.3M 63.66M 49.98M